EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
HyperinsulinemiaInsulin ResistanceObesity
Interventions
DRUG

metformin and rosiglitazone

4 week dosage escalation of metformin, 500 mg/day (or placebo) to a total dose of 2000mg/day; starting dose of rosiglitazone 2mg/day(or placebo) added at weeks 3 and weeks 4 to a a total dose of 4 mg/day

Trial Locations (1)

10461

Albert Einstein College of Medicine, The Bronx

Sponsors
All Listed Sponsors
collaborator

Albert Einstein College of Medicine

OTHER

collaborator

University of Tennessee

OTHER

lead

New York Medical College

OTHER